| Cvs Pharmacy #01145 | |
| 751 W Tuscan Street 121st, Broken Arrow, Oklahoma 74011 | |
| (918) 455-0089 |
| Name | Cvs Pharmacy #01145 |
|---|---|
| Organization Name | Oklahoma Cvs Pharmacy Llc |
| Location | 751 W Tuscan Street 121st, Broken Arrow, Oklahoma 74011 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (918) 455-0089 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.
The Food and Drug Administration (FDA) has issued a Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior ("suicidality") in children and adolescents being treated with antidepressant medications.
Itchy irritated skin can leave some people scratching their heads trying to determine the cause of this bothersome condition. What did they touch? Is it just dry skin gone awry? Are they allergic to something in their home or workplace? The answers to these questions could require not only a little detective work, but the help of a dermatologist who can diagnose and treat the most likely culprit - contact dermatitis.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 8 days ago
| NPI Number | 1942524061 |
| Organization Name | OKLAHOMA CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #01145 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 751 W Tuscan St, 121st, Broken Arrow, OK 74011 |
| Phone Number | 918-455-0089 |
News Archive
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.
The Food and Drug Administration (FDA) has issued a Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior ("suicidality") in children and adolescents being treated with antidepressant medications.
Itchy irritated skin can leave some people scratching their heads trying to determine the cause of this bothersome condition. What did they touch? Is it just dry skin gone awry? Are they allergic to something in their home or workplace? The answers to these questions could require not only a little detective work, but the help of a dermatologist who can diagnose and treat the most likely culprit - contact dermatitis.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 8 days ago
News Archive
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.
The Food and Drug Administration (FDA) has issued a Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior ("suicidality") in children and adolescents being treated with antidepressant medications.
Itchy irritated skin can leave some people scratching their heads trying to determine the cause of this bothersome condition. What did they touch? Is it just dry skin gone awry? Are they allergic to something in their home or workplace? The answers to these questions could require not only a little detective work, but the help of a dermatologist who can diagnose and treat the most likely culprit - contact dermatitis.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 8 days ago
Cvs Pharmacy #08279 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2351 N 9th St, Broken Arrow, Oklahoma 74012 Phone: (918) 355-1293 | |
Cvs Pharmacy #01145 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 751 W Tuscan Street 121st, Broken Arrow, Oklahoma 74011 Phone: (918) 455-0089 | |
Cvs Pharmacy #04896 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1853 S Aspen Ave, Broken Arrow, Oklahoma 74012 Phone: (918) 251-9615 | |
Cvs Pharmacy #17479 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1150 E Hillside Dr, Broken Arrow, Oklahoma 74012 Phone: (918) 615-1901 | |
Walgreens #3040 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 701 W Houston St, Broken Arrow, Oklahoma 74012 Phone: (918) 251-7924 |